| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Antonia Manduca, Valeria Buzzelli, Alessandro Rava, Alessandro Feo, Emilia Carbone, Sara Schiavi, Barbara Peruzzi, Valentina D'Oria, Marco Pezzullo, Andrea Pasquadibisceglie, Fabio Polticelli, Vincenzo Micale, Martin Kuchar, Viviana Trezz. Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: obligatory role of hippocampal GPR55 receptors. Pharmacological research. 2024-04-07. PMID:38583687. |
cannabidiol (cbd), a non-psychotomimetic constituent of cannabis sativa, has been recently approved for epileptic syndromes often associated with autism spectrum disorder (asd). |
2024-04-07 |
2024-04-10 |
Not clear |
| Abay Woday Tadesse, Berihun Assefa Dachew, Getinet Ayano, Kim Betts, Rosa Alat. Prenatal cannabis use and the risk of attention deficit hyperactivity disorder and autism spectrum disorder in offspring: A systematic review and meta-analysis. Journal of psychiatric research. vol 171. 2024-01-28. PMID:38281464. |
prenatal cannabis use and the risk of attention deficit hyperactivity disorder and autism spectrum disorder in offspring: a systematic review and meta-analysis. |
2024-01-28 |
2024-01-31 |
Not clear |
| Abay Woday Tadesse, Berihun Assefa Dachew, Getinet Ayano, Kim Betts, Rosa Alat. Prenatal cannabis use and the risk of attention deficit hyperactivity disorder and autism spectrum disorder in offspring: A systematic review and meta-analysis. Journal of psychiatric research. vol 171. 2024-01-28. PMID:38281464. |
it is plausible that exposure to cannabis in-utero could be associated with an increased risk of neurodevelopmental disorders such as attention deficit hyperactivity disorder (adhd) symptoms and autism spectrum disorder (asd) during childhood and adolescence; however, mixed results have been reported. |
2024-01-28 |
2024-01-31 |
Not clear |
| Jean-Christophe Quillet, Michael Siani-Rose, Robert McKee, Bonni Goldstein, Myiesha Taylor, Itzhak Kure. A machine learning approach for understanding the metabolomics response of children with autism spectrum disorder to medical cannabis treatment. Scientific reports. vol 13. issue 1. 2023-08-22. PMID:37608004. |
a machine learning approach for understanding the metabolomics response of children with autism spectrum disorder to medical cannabis treatment. |
2023-08-22 |
2023-09-07 |
Not clear |
| Jenika Staben, Megan Koch, Keelee Reid, Jessica Muckerheide, Lauren Gilman, Finn McGuinness, Sarina Kiesser, Iain W H Oswald, Kevin A Koby, Thomas J Martin, Joshua S Kapla. Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder. Frontiers in neuroscience. vol 17. 2023-07-03. PMID:37397463. |
cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the btbr mouse model of autism spectrum disorder. |
2023-07-03 |
2023-08-14 |
mouse |
| Jenika Staben, Megan Koch, Keelee Reid, Jessica Muckerheide, Lauren Gilman, Finn McGuinness, Sarina Kiesser, Iain W H Oswald, Kevin A Koby, Thomas J Martin, Joshua S Kapla. Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder. Frontiers in neuroscience. vol 17. 2023-07-03. PMID:37397463. |
cannabidiol (cbd) is a non-intoxicating phytocannabinoid with increasing popularity due to its purported therapeutic efficacy for numerous off-label conditions including anxiety and autism spectrum disorder (asd). |
2023-07-03 |
2023-08-14 |
mouse |
| Daryl Efron, Kaitlyn Taylo. Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders. International journal of environmental research and public health. vol 20. issue 8. 2023-04-28. PMID:37107712. |
preliminary evidence from open-label studies suggests the potential for medicinal cannabis to ameliorate some symptoms in children with autism spectrum disorder. |
2023-04-28 |
2023-08-14 |
Not clear |
| Daryl Efron, Kaitlyn Taylo. Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders. International journal of environmental research and public health. vol 20. issue 8. 2023-04-28. PMID:37107712. |
studies of medicinal cannabis are planned or underway for children and/or adolescents with autism, intellectual disability, tourette's syndrome, anxiety, psychosis, anorexia nervosa and a number of specific neurodevelopmental syndromes. |
2023-04-28 |
2023-08-14 |
Not clear |
| C Nutor, A Dunlop, O Sadler, P A Brenna. Prenatal Cannabis Use and Offspring Autism-Related Behaviors: Examining Maternal Stress as a Moderator in a Black American Cohort. Journal of autism and developmental disorders. 2023-04-25. PMID:37097527. |
prenatal cannabis use and maternal stress have been proposed as risk factors for autism spectrum disorder (asd). |
2023-04-25 |
2023-08-14 |
Not clear |
| Avanti Adhia, Megan Bair-Merritt, Sarabeth Broder-Fingert, Rocio A Nunez Pepen, Annieliesa C Suarez-Rocha, Emily F Rothma. The Critical Lack of Data on Alcohol and Marijuana Use by Adolescents on the Autism Spectrum. Autism in adulthood : challenges and management. vol 2. issue 4. 2023-01-05. PMID:36600961. |
of these, only one included information about both autism and alcohol and/or marijuana by youth. |
2023-01-05 |
2023-08-14 |
Not clear |
| Fangru Wang, Ting Jin, Hongyuan Li, Houfang Long, Ying Liu, Sha Jin, Yuyuan Lu, Yinghua Peng, Cong Liu, Lihui Zhao, Xiaohui Wan. Cannabidivarin alleviates α-synuclein aggregation via DAF-16 in Caenorhabditis elegans. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 37. issue 2. 2022-12-30. PMID:36583706. |
cannabidivarin (cbdv), a structural analog of cannabidiol (cbd), has received attention in recent years owing to its anticonvulsant property and potential for treating autism spectrum disorder. |
2022-12-30 |
2023-08-14 |
caenorhabditis_elegans |
| Noa Raz, Iso Heller, Titti Lombardi, Giorgio Marino, Elyad M Davidson, Aharon M Eya. Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report. Frontiers in pharmacology. vol 13. 2022-11-17. PMID:36386202. |
cannabidiol (cbd) rich products are successfully used in some countries for treating symptoms associated with autism spectrum disorder (asd). |
2022-11-17 |
2023-08-14 |
human |
| Rick Wilhiam de Camargo, Linério Ribeiro de Novais Júnior, Larissa Mendes da Silva, Vicente Meneguzzo, Guilherme Cabreira Daros, Marina Goulart da Silva, Rafael Mariano de Bitencour. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review. Pharmacology, biochemistry, and behavior. 2022-11-15. PMID:36379443. |
due to the health and quality of life impacts of autism for the patient and his/her family and the lack of effective medications, the literature has elucidated the possibility that cannabis phytocannabinoids act favorably on asd symptoms, probably through the modulation of neurotransmitters, in addition to endogenous ligands derived from arachidonic acid, metabolizing enzymes and even transporters of the membrane. |
2022-11-15 |
2023-08-14 |
Not clear |
| Orit Stolar, Ariela Hazan, Roni Enten Vissoker, Ibrahim Abu Kishk, Dana Barchel, Mirit Lezinger, Adi Dagan, Nir Treves, David Meiri, Matitiahu Berkovitch, Elkana Kohn, Eli Heyma. Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety. Frontiers in pharmacology. vol 13. 2022-10-17. PMID:36249785. |
medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: an interim analysis of biochemical safety. |
2022-10-17 |
2023-08-14 |
Not clear |
| Lucy Ma, Sofia Platnick, Howard Platnic. Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study. Cureus. vol 14. issue 8. 2022-09-30. PMID:36176817. |
cannabidiol in treatment of autism spectrum disorder: a case study. |
2022-09-30 |
2023-08-14 |
Not clear |
| Lucy Ma, Sofia Platnick, Howard Platnic. Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study. Cureus. vol 14. issue 8. 2022-09-30. PMID:36176817. |
this case study aims to demonstrate the use of cannabidiol (cbd) with low-dose tetrahydrocannabinol (thc) in managing symptoms associated with autism spectrum disorder (asd) to increase the overall quality of life for these individuals and their families. |
2022-09-30 |
2023-08-14 |
Not clear |
| Simon Erridge, Jess Kerr-Gaffney, Carl Holvey, Ross Coomber, Daniela A Riano Barros, Urmila Bhoskar, Gracia Mwimba, Kavita Praveen, Chris Symeon, Simmi Sachdeva-Mohan, Mikael H Sodergren, James J Rucke. Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry. Therapeutic advances in psychopharmacology. vol 12. 2022-09-26. PMID:36159065. |
clinical outcome analysis of patients with autism spectrum disorder: analysis from the uk medical cannabis registry. |
2022-09-26 |
2023-08-14 |
Not clear |
| Riccardo Bortoletto, Marco Colizz. Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis. Healthcare (Basel, Switzerland). vol 10. issue 8. 2022-08-26. PMID:36011210. |
cannabis use in autism: reasons for concern about risk for psychosis. |
2022-08-26 |
2023-08-14 |
Not clear |
| João F C Pedrazzi, Frederico R Ferreira, Danyelle Silva-Amaral, Daniel A Lima, Jaime E C Hallak, Antônio W Zuardi, Elaine A Del-Bel, Francisco S Guimarães, Karla C M Costa, Alline C Campos, Ana C S Crippa, José A S Cripp. Cannabidiol for the treatment of autism spectrum disorder: hope or hype? Psychopharmacology. 2022-07-29. PMID:35904579. |
cannabidiol for the treatment of autism spectrum disorder: hope or hype? |
2022-07-29 |
2023-08-14 |
Not clear |
| Albert Stuart Reece, Gary Kenneth Huls. Impact of converging sociocultural and substance-related trends on US autism rates: combined geospatiotemporal and causal inferential analysis. European archives of psychiatry and clinical neuroscience. 2022-07-02. PMID:35779123. |
whilst cannabis is known to be toxic to brain development, it is unknown if it is driving rising us autism rates (asmr). |
2022-07-02 |
2023-08-14 |
Not clear |